Medicine
Cytarabine 500 mg/25 mL injection
Cytarabine 500 mg/25 mL injection is a generic prescription medicine for intravenous, subcutaneous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C…
Key facts
- Active ingredient (INN)
- Cytarabine
- Brand
- Sold under the generic name
- Strength
- 500 mg/25 mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Packs
- 1 vial of 25 mL
- Manufacturers
- HospiraMeitheal Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° and 86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01BC01 Cytarabine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 February 1994
- Identifiers
- RxCUI 240416DailyMed set ID 8b366382-c8d1-4344-86b7-f65e92a8952b, 21e8e8e6-3f85-4fdd-8452-c9d14d2ef69aNDC 71288-169, 61703-304Application ANDA208485, ANDA072945
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, multi-dose in 1 carton / 25 mL in 1 vial, multi-dose | 61703-304-36 | Hospira | 28 February 1994 |
| 1 vial, multi-dose in 1 carton / 25 mL in 1 vial, multi-dose | 71288-169-25 | Meitheal Pharmaceuticals | 28 February 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cytarabine
Clinical summary
Cytarabine is a nucleoside metabolic inhibitor indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. It is available as injection for intravenous, subcutaneous and intrathecal use. MedsAcross supplies Cytarabine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CytarabineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cytarabine prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Cytarabine 500 mg/25 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.